Co-Authors
This is a "connection" page, showing publications co-authored by Jason Glanz and Lei Qian.
Connection Strength
0.570
-
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. Vaccine. 2023 01 16; 41(3):844-854.
Score: 0.208
-
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. Vaccine. 2022 05 20; 40(23):3150-3158.
Score: 0.198
-
Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 May; 56(3):513-25.
Score: 0.112
-
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013 May 24; 31(22):2578-83.
Score: 0.027
-
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2013 Feb; 56(3):315-21.
Score: 0.026